pureosbio.com - Home - Pureos Bioventures

home > domains > pureosbio.com

Description: Venture capital for companies developing innovative therapeutics.

Example domain paragraphs

Latest News Alentis Therapeutics announces USD 105 Million USD Series C News: Mehr erfahren Venture capital for companies developing innovative therapeutics Strategy Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases.

Our companies are developing innovative therapeutics for severe diseases and conditions. We are backing great teams with development programs that make a true difference for patients.

Acrivon Therapeutics is a clinical stage oncology company developing novel cancer drugs paired with companion diagnostics predicting treatment response and driving patient selection. In November 2022, Acrivon went public at the NASDAQ (ACRV).

Links to pureosbio.com (4)

• bellevue.ch Bellevue Group AG
• bellevueprivatemarkets.ch Private Market Investments | Bellevue Group AG
• starcapital.de Bellevue Group AG - Asset Management | Bellevue Group AG
• bbsilkroad.com Bellevue Group AG